BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 34384835)

  • 1. Cohort and nested case-control study of cutaneous squamous cell carcinoma in solid organ transplant recipients, by medication.
    Dusendang JR; Carlson E; Lee DS; Marwaha S; Madani S; Alexeeff SE; Webber A; Goes NB; Herrinton LJ
    J Am Acad Dermatol; 2022 Mar; 86(3):598-606. PubMed ID: 34384835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation.
    Vos M; Plasmeijer EI; van Bemmel BC; van der Bij W; Klaver NS; Erasmus ME; de Bock GH; Verschuuren EAM; Rácz E
    J Heart Lung Transplant; 2018 Jul; 37(7):853-859. PubMed ID: 29680587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs).
    Asgari MM; Arron ST; Warton EM; Quesenberry CP; Weisshaar D
    J Am Acad Dermatol; 2015 Sep; 73(3):444-50. PubMed ID: 26138646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017.
    Sargen MR; Cahoon EK; Lynch CF; Tucker MA; Goldstein AM; Engels EA
    JAMA Dermatol; 2020 Dec; 156(12):1307-1314. PubMed ID: 33146669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous squamous cell carcinoma (cSCC) and immunosurveillance - the impact of immunosuppression on frequency of cSCC.
    Plasmeijer EI; Sachse MM; Gebhardt C; Geusau A; Bouwes Bavinck JN
    J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():33-37. PubMed ID: 31833604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative incidence and risk factors for cutaneous squamous cell carcinoma metastases in organ transplant recipients: The Skin Care in Organ Transplant Patients in Europe-International Transplant Skin Cancer Collaborative metastases study, a prospective multicenter study.
    de Jong E; Genders R; Harwood CA; Green AC; Plasmeijer EI; Proby C; Geissler E; Ferrándiz-Pulido C; Ducroux E; Euvrard S; Geusau A; Jahn-Bassler K; Borik-Heil L; Rácz E; Nägeli M; Hofbauer GFL; Piaserico S; Russo I; Mackintosh L; Borges-Costa J; Angeliki-Gkini M; Zavattaro E; Savoia P; Imko-Walszuk B; Dębska-Slizień A; Garmyn M; van Kelst S; Ricar J; Cetkovska P; Matin R; Güleç AT; Seçkin D; Anene CA; Oliveira WRP; Rademaker M; Goeman J; van Geloven N; Ruiz E; Murad F; Karn E; Schmults CD; Bouwes Bavinck JN
    J Am Acad Dermatol; 2024 Jun; 90(6):1200-1209. PubMed ID: 38301923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
    Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
    Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
    D'Arcy ME; Pfeiffer RM; Rivera DR; Hess GP; Cahoon EK; Arron ST; Brownell I; Cowen EW; Israni AK; Triplette MA; Yanik EL; Engels EA
    JAMA Dermatol; 2020 Jul; 156(7):772-779. PubMed ID: 32401271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous Squamous Cell Carcinomas in Solid Organ Transplant Recipients Compared With Immunocompetent Patients.
    Cheng JY; Li FY; Ko CJ; Colegio OR
    JAMA Dermatol; 2018 Jan; 154(1):60-66. PubMed ID: 29167858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous squamous cell carcinoma in the organ transplant recipient.
    Bibee K; Swartz A; Sridharan S; Kurten CHL; Wessel CB; Skinner H; Zandberg DP
    Oral Oncol; 2020 Apr; 103():104562. PubMed ID: 32065978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin Cancers and Lung Transplant.
    Wilken R; Carucci J; Stevenson ML
    Semin Respir Crit Care Med; 2021 Jun; 42(3):483-496. PubMed ID: 34030209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients.
    Mansh M; Binstock M; Williams K; Hafeez F; Kim J; Glidden D; Boettger R; Hays S; Kukreja J; Golden J; Asgari MM; Chin-Hong P; Singer JP; Arron ST
    Am J Transplant; 2016 Jan; 16(1):262-70. PubMed ID: 26372838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.
    Feist A; Lee R; Osborne S; Lane J; Yung G
    J Heart Lung Transplant; 2012 Nov; 31(11):1177-81. PubMed ID: 22841559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity against Non-Melanoma Skin Cancer and the Effect of Immunosuppressive Medication on Non-Melanoma Skin Cancer Risk in Solid Organ Transplant Recipients.
    Bakker D; Bakker WJ; Bekkenk MW; Luiten RM
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement.
    Massey PR; Schmults CD; Li SJ; Arron ST; Asgari MM; Bouwes Bavinck JN; Billingsley E; Blalock TW; Blasdale K; Carroll BT; Carucci JA; Chong AH; Christensen SR; Chung CL; DeSimone JA; Ducroux E; Escutia-Muñoz B; Ferrándiz-Pulido C; Fox MC; Genders RE; Geusau A; Gjersvik P; Hanlon AM; Olasz Harken EB; Hofbauer GFL; Hopkins RS; Leitenberger JJ; Loss MJ; Del Marmol V; Mascaró JM; Myers SA; Nguyen BT; Oliveira WRP; Otley CC; Proby CM; Rácz E; Ruiz-Salas V; Samie FH; Seçkin D; Shah SN; Shin TM; Shumack SP; Soon SL; Stasko T; Zavattaro E; Zeitouni NC; Zwald FO; Harwood CA; Jambusaria-Pahlajani A
    JAMA Dermatol; 2021 Oct; 157(10):1219-1226. PubMed ID: 34468690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment on "Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs)".
    Longo MI; Wen X; Womer KL
    J Am Acad Dermatol; 2016 May; 74(5):e105-6. PubMed ID: 27085243
    [No Abstract]   [Full Text] [Related]  

  • 17. Rates of Second Tumor, Metastasis, and Death From Cutaneous Squamous Cell Carcinoma in Patients With and Without Transplant-Associated Immunosuppression.
    Gjersvik P; Falk RS; Roscher I; Rizvi SMH; Mjøen G; Gude E; Leuckfeld I; Boberg KM; Veierød MB; Robsahm TE
    JAMA Dermatol; 2023 Sep; 159(9):923-929. PubMed ID: 37466985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US.
    Sargen MR; Cahoon EK; Yu KJ; Madeleine MM; Zeng Y; Rees JR; Lynch CF; Engels EA
    JAMA Dermatol; 2022 Apr; 158(4):414-425. PubMed ID: 35262623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cumulative incidence and timing of subsequent cutaneous squamous cell carcinomas stratified for patients with organ transplantation and hematologic malignancies: A nationwide cohort study.
    Eggermont CJ; Hollestein LM; Hollatz A; Louwman M; Mooyaart AL; Nijsten T; Wakkee M
    J Am Acad Dermatol; 2024 Mar; 90(3):530-536. PubMed ID: 37871807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin and gut microbial associations with squamous cell carcinoma in solid organ transplant recipients.
    Ha MV; McCormick TS; Salem I; Al-Shakhshir H; Ghannoum MA; Carroll BT
    Arch Dermatol Res; 2023 Nov; 315(9):2709-2713. PubMed ID: 37278910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.